Mission to eliminate cancer and target circulating tumor stem cell clusters at the Pharm Dept @NUFeinbergMed @LurieCancer center, as a member of @the_asci.
“We can cure primary tumors by surgery or radiation. However, when tumor cells start spreading from one place to another, they can get out of control. A lot of times it is devastating and incurable,” Huiping Liu, MD, PhD (@LiuCluster), said.
“It’s a very significant problem in the clinic and also affects patient outcomes and survival time.” https://t.co/KlmvANzVBU
@NUfeinbergmed #BreastCancer #CirculatingTumorCells #DPCells
Shout out to @LiuCluster who was co-author of a study published in @ScienceTM on how a group of cancer cells circulating the bloodstream may play a bigger role in breast cancer progression.
Read Here: https://t.co/2CSecuXYxW
Thanks for the inspiring lightning talks brought by Brian Ivan Molina Diaz, Zachary Franklin Greenberg, Elizabeth Wang, Sichen Zhang, Hannah Almubarak, Junlang Li and Xiao Cheng!
We are delighted to celebrate the election of our esteemed colleague, Dr. Joe Bass, @JoeBass91471540 to the @theNAMedicine. This honor recognizes his outstanding contributions to the field of Endocrinology, Metabolism, and Molecular Medicine, and his pioneering research elucidating the critical links between the body’s circadian rhythms and metabolic regulation. Dr. Bass’s groundbreaking work has revealed how disruptions in the circadian system contribute to metabolic diseases such as diabetes and obesity. This election represents a well-deserved and long-overdue recognition of Dr. Bass’s exceptional scientific achievements and his profound impact on the field. Congratulations, Joe, on this remarkable and richly merited honor. @NU_BMG_SQE@NUFeinbergMed@theNASciences
An unexpected discovery by Lurie Cancer Center member and #CZBiohubChicago President @ShanaOKelley may inform the development of new mutation-specific therapeutic strategies for treating mutant #KRAS-driven cancers, according to findings in @nchembio https://t.co/xKJUoRd2Fu
Our deputy director, Maha Hussain, in my office showing me the Lifetime Achievement Award she got from the PCF for her remarkable clinical research that has transformed the prostate cancer field, led to several FDA approvals and prolonged many lives! @LurieCancer
This is intriguing work coming from @LurieCancer, highlighting critical cellular dynamics that could be pivotal in addressing metastasis in #breastcancer. With cancer cells leveraging immune cell interactions for spread, what implications does this have for developing targeted therapies? For more in-depth, personalized insights on similar topics in #Medicine and #CancerResearch, check out https://t.co/4Y9Imt8uIJ. It's the go-to platform for generating comprehensive biomedical reviews tailored to your inquiries.
Can we root out the seeds of metastasis?
@LiuCluster & team @NUFeinbergMed identify a rare T cell subset that cluster circulating tumor cells to promote metastasis in breast cancer, then provide a proof-of-concept block using VLA-4 antibody in preclinical models: https://t.co/oZd0wUe2tc
Huiping Liu, MD, PhD (@LiuCluster), and team reveal how tumor–immune cell clusters fuel #BreastCancer metastasis in a pair of new studies published in @NatureComms and @jclinicalinvest. https://t.co/nISnPzEK9W
In a pair of studies, investigators from the lab of @LurieCancer's Huiping Liu, MD, PhD, have uncovered how cellular interactions in the bloodstream may be fueling the spread of #breastcancer. https://t.co/XavmgB0ecg via @NUFeinbergMed#CTC#BTSM